Research map: A Novel Imaging-Based Approach for Large Extracellular Vesicle Detection and Prognostic Stratification in Metastatic Breast Cancer

Back to the article

Papers in this map

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches · Joshua A Welsh · 2024 · 4417 citations · Cited by this paper
  2. Platelet gene expression profiling as a liquid biopsy tool to monitor Immunotherapy resistance in advanced NSCLC patients · 2025 · Related
  3. Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease · Dolores Di Vizio · 2009 · 422 citations · Cited by this paper
  4. Validation of NEO PanTracer LBx, a liquid biopsy, precision oncology pan-solid tumor comprehensive genomic profiling assay (CGP) · 2025 · Related
  5. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles · Valentina R. Minciacchi · 2015 · 413 citations · Cited by this paper
  6. Plasma and Pleural Effusion as reflective mirrors of the Immune Landscape in two histotypes of Pleural Mesothelioma · 2025 · Related
  7. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer · Kyung-A Hyun · 2016 · 291 citations · Cited by this paper
  8. ctDNA clearance of epigenetic regulators and HRR mutations predicts immunotherapy response in advanced head and neck cancer. · 2025 · Related
  9. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer · Frank A. W. Coumans · 2010 · 211 citations · Cited by this paper
  10. Multimodal ctDNA profiling identifies fragmentomics and tumor fraction as independent prognostic biomarkers of ovarian cancer survival: the MITO-16a/MANGO-OV2a trial experience · 2025 · Related
  11. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation · Chiara Ciardiello · 2019 · 128 citations · Cited by this paper
  12. Non-invasive identification of actionable biomarkers in advanced solid tumors by comprehensive genomic profiling with NEO | PanTracer LBx assay · 2025 · Related
  13. Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients · Afroditi Nanou · 2018 · 75 citations · Cited by this paper
  14. The RI-MUHC Circulating Biomarkers in Health & Disease Network: Advancing Translational cfDNA Research Through an Interdisciplinary Framework · 2025 · Related
  15. Single tube liquid biopsy for advanced non‐small cell lung cancer · Sanne de Wit · 2018 · 75 citations · Cited by this paper
  16. High performance of cancer detection with using single-strand circulating DNA fragment end motif analysis · 2025 · Related
  17. The RareCyte® platform for next‐generation analysis of circulating tumor cells · Eric Peter Kaldjian · 2018 · 68 citations · Cited by this paper
  18. Analytical and clinical validation of a novel CE-IVD kit for PIK3CA hotspot mutations in liquid biopsy samples · 2026 · Related
  19. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer · Afroditi Nanou · 2020 · 58 citations · Cited by this paper
  20. Harmonizing definitions in liquid biopsy: A terminology framework by the international society of liquid biopsy · 2026 · Related
  21. Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer · Steffi Oeyen · 2020 · 52 citations · Cited by this paper
  22. A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes · Irene Bertolini · 2019 · 48 citations · Cited by this paper
  23. Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer · Anna Sandström Gerdtsson · 2021 · 48 citations · Cited by this paper
  24. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value · André Franken · 2023 · 44 citations · Cited by this paper
  25. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer · Luc Yves Dirix · 2022 · 43 citations · Cited by this paper
  26. Extracellular vesicle heterogeneity through the lens of multiomics · Taylon Felipe Silva · 2025 · 42 citations · Cited by this paper
  27. CTC Technologies and Tools · Frank A. W. Coumans · 2018 · 29 citations · Cited by this paper
  28. Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer · Sonia Maryam Setayesh · 2022 · 25 citations · Cited by this paper
  29. Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer · Afroditi Nanou · 2023 · 20 citations · Cited by this paper
  30. Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients · Khrystany T. Isebia · 2022 · 16 citations · Cited by this paper
  31. Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer · Stefan A. Cieslik · 2025 · 6 citations · Cited by this paper
  32. Association between EPCAM upregulation and clinicopathological parameters and outcomes of breast cancer · Nahid Nafissi · 2024 · 3 citations · Cited by this paper
  33. Abstract 1147: Development of a novel assay to detect circulating tumor cells in the cerebrospinal fluid of patients with leptomeningeal disease · Laura Ann Huppert · 2025 · 2 citations · Cited by this paper
  34. Mechanisms and functions of large extracellular vesicle biogenesis · Stephanie F. Rutter · 2026 · 2 citations · Cited by this paper
  35. Abstract 1968: Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: Potential new analyte for biomarker monitoring? · Eszter Papp · 2025 · 1 citation · Cited by this paper
  36. 23P Combining circulating tumor cells (CTCs) and tumor-derived extracellular vesical (tdEVs) for prognosis stratification in metastatic breast cancer (mBC) · E. Nicolo · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)